Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide

Clinical trial NCT00871585 · COMPLETED

Trial details

NCT number: NCT00871585
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Advanced Prostate Cancer

Start date: 2009-03-01
Primary completion: 2010-01-01
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.